What Can We Still Learn from Brain Autopsies in COVID-19?

Abstract

Neuropathological findings have been published from ∼900 patients who died with or from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, representing less than 0.01% of the close to 6.4 million deaths reported to the World Health Organization 2 years into the coronavirus disease 2019 (COVID-19) pandemic. In this review, we extend our prior work summarizing COVID-19 neuropathology by including information on published autopsies up to June 2022, and neuropathological studies in children, COVID-19 variants, secondary brain infections, ex vivo brain imaging, and autopsies performed in countries outside of the United States or Europe. We also summarize research studies that investigate mechanisms of neuropathogenesis in nonhuman primates and other models. While a pattern of cerebrovascular pathology and microglial-predominant inflammation remains the primary COVID-19-associated neuropathological finding, there is no singular understanding of the mechanisms that underlie neurological symptoms in acute COVID-19 or the post-acute COVID-19 condition. Thus, it is paramount that we incorporate microscopic and molecular findings from brain tissue into what we know about the clinical disease so that we attain best practice guidance and direct research priorities for the study of the neurological morbidity of COVID-19.

Keywords

COVID-19 - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - brain autopsies - neuropathological findings - children with COVID-19 - Rhino-orbito-cerebral mucormycosis COVID-19 Neuropathogenesis

Author Contributions

I.H.S. was involved in the conceptualization, writing, reviewing, and editing of the manuscript, and figure generation. A.S. was involved in the writing and editing of the manuscript. R.D.F. was involved in the editing of the manuscript and figure generation. S.S.M. was involved in the conceptualization, writing, reviewing, and editing of the manuscript, and supervision.

Publikationsverlauf

Artikel online veröffentlicht:
06. April 2023

• References

• 1 Mukerji SS, Solomon IH. What can we learn from brain autopsies in COVID-19?. Neurosci Lett 2021; 742: 135528
• 2 Rakislova N, Marimon L, Ismail MR. et al. Minimally invasive autopsy practice in COVID-19 cases: biosafety and findings. Pathogens 2021; 10 (04) 10
• 3 Bryce C, Grimes Z, Pujadas E. et al. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol 2021; 34 (08) 1456-1467
• 4 El Jamal SM, Pujadas E, Ramos I. et al. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: sustained direct viral-induced damage is not necessary to drive disease progression. Hum Pathol 2021; 114: 110-119
• 5 Serrano GE, Walker JE, Tremblay C. et al. SARS-CoV-2 brain regional detection, histopathology, gene expression, and immunomodulatory changes in decedents with COVID-19. J Neuropathol Exp Neurol 2022; 81 (09) 666-695
• 6 Thakur KT, Miller EH, Glendinning MD. et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain 2021; 144 (09) 2696-2708
• 7 Jackson NR, Zeigler K, Torrez M. et al. New Mexico's COVID-19 experience. Am J Forensic Med Pathol 2021; 42 (01) 1-8
• 8 Lee MH, Perl DP, Nair G. et al. Microvascular injury in the brains of patients with Covid-19. N Engl J Med 2021; 384 (05) 481-483
• 9 Lee MH, Perl DP, Steiner J. et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain 2022; 145 (07) 2555-2568
• 10 Wierzba-Bobrowicz T, Krajewski P, Tarka S. et al. Neuropathological analysis of the brains of fifty-two patients with COVID-19. Folia Neuropathol 2021; 59 (03) 219-231
• 11 Colombo D, Falasca L, Marchioni L. et al. Neuropathology and inflammatory cell characterization in 10 autoptic COVID-19 brains. Cells 2021; 10 (09) 10
• 12 Lopez G, Tonello C, Osipova G. et al. Olfactory bulb SARS-CoV-2 infection is not paralleled by the presence of virus in other central nervous system areas. Neuropathol Appl Neurobiol 2022; 48 (01) e12752
• 13 Poloni TE, Medici V, Moretti M. et al. COVID-19-related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol 2021; 31 (05) e12997
• 14 Gagliardi S, Poloni ET, Pandini C. et al. Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients. Brain Behav Immun 2021; 97: 13-21
• 15 Fabbri VP, Riefolo M, Lazzarotto T. et al. COVID-19 and the brain: the neuropathological Italian experience on 33 adult autopsies. Biomolecules 2022; 12 (05) 12
• 16 Hirschbühl K, Dintner S, Beer M. et al. Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: a multiorgan and multimethodological approach. PLoS One 2021; 16 (07) e0254872
• 17 Meinhardt J, Radke J, Dittmayer C. et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 2021; 24 (02) 168-175
• 18 Greuel S, Ihlow J, Dragomir MP. et al. COVID-19: autopsy findings in six patients between 26 and 46 years of age. Int J Infect Dis 2021; 108: 274-281
• 19 Ruz-Caracuel I, Pian-Arias H, Corral Í. et al. Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations. Pathology 2022; 54 (06) 738-745
• 20 Mikhaleva LM, Cherniaev AL, Samsonova MV. et al. Pathological features in 100 deceased patients with COVID-19 in correlation with clinical and laboratory data. Pathol Oncol Res 2021; 27: 1609900
• 21 Bugra A, Das T, Arslan MN, Ziyade N, Buyuk Y. Postmortem pathological changes in extrapulmonary organs in SARS-CoV-2 rt-PCR-positive cases: a single-center experience. Ir J Med Sci 2022; 191 (01) 81-91
• 22 Himwaze CM, Telendiy V, Maate F. et al. Post-mortem examination of hospital inpatient COVID-19 deaths in Lusaka, Zambia - a descriptive whole-body autopsy series. Int J Infect Dis 2021; 108: 363-369
• 23 Attoh S, Segborwotso RP, Akoriyea SK. et al. COVID-19 autopsy reports from the Ga-East Municipal and the 37 Military Hospitals in Accra, Ghana. Ghana Med J 2020; 54 (4, Suppl): 52-61
• 24 Santana MF, Frank CHM, Almeida TVR. et al. Hemorrhagic and thrombotic manifestations in the central nervous system in COVID-19: a large observational study in the Brazilian Amazon with a complete autopsy series. PLoS One 2021; 16 (09) e0255950
• 25 Yang AC, Kern F, Losada PM. et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 2021; 595 (7868): 565-571
• 26 Dittmayer C, Laue M. Continued false-positive detection of SARS-CoV-2 by electron microscopy. Ann Neurol 2022; 92 (02) 340-341
• 27 Krasemann S, Dittmayer CV, Stillfried S. et al. Assessing and improving the validity of COVID-19 autopsy studies - a multicentre approach to establish essential standards for immunohistochemical and ultrastructural analyses. EBioMedicine 2022; 83: 104193 . Doi: https://doi.org/10.1016/j.ebiom.2022.104193
• 28 Ho CY, Salimian M, Hegert J. et al. Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19. JAMA Neurol 2022; 79 (06) 544-553
• 29 de Melo GD, Lazarini F, Levallois S. et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med 2021; 13 (596) 13
• 30 Pipolo C, Bottai D, Fuccillo E. et al. Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients. PLoS One 2022; 17 (04) e0266740
• 31 Khan M, Yoo SJ, Clijsters M. et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell 2021; 184 (24) 5932-5949 .e15
• 32 Valizadeh N, Rudmann EA, Solomon IH, Mukerji SS. Mechanisms of entry into the central nervous system by neuroinvasive pathogens. J Neuroophthalmol 2022; 42 (02) 163-172
• 33 Penkava J, Muenchhoff M, Badell I. et al. Detection of SARS-CoV-2-RNA in post-mortem samples of human eyes. Graefes Arch Clin Exp Ophthalmol 2022; 260 (05) 1789-1797
• 34 Bayyoud T, Iftner A, Iftner T. et al. Severe acute respiratory syndrome-coronavirus-2: can it be detected in the retina?. PLoS One 2021; 16 (05) e0251682
• 35 Casagrande M, Fitzek A, Spitzer M. et al. Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19. Br J Ophthalmol 2022; 106 (09) 1313-1317
• 36 Casagrande M, Fitzek A, Spitzer MS. et al. Presence of SARS-CoV-2 RNA in the cornea of viremic patients with COVID-19. JAMA Ophthalmol 2021; 139 (04) 383-388
• 37 Duarte-Neto AN, Caldini EG, Gomes-Gouvêa MS. et al. An autopsy study of the spectrum of severe COVID-19 in children: from SARS to different phenotypes of MIS-C. EClinicalMedicine 2021; 35: 100850
• 38 Poisson KE, Zygmunt A, Leino D. et al. Lethal pediatric cerebral vasculitis triggered by severe acute respiratory syndrome coronavirus 2. Pediatr Neurol 2022; 127: 1-5
• 39 Ninan S, Thompson P, Gershon T. et al. Fatal pediatric COVID-19 case with seizures and fulminant cerebral edema. Child Neurol Open 2021; 8: 23 29048X211022532
• 40 Stram MN, Seifert AC, Cortes E. et al. Neuropathology of pediatric SARS-CoV-2 infection in the forensic setting: novel application of ex vivo imaging in analysis of brain microvasculature. Front Neurol 2022; 13: 894565
• 41 Walker JM, Gilbert AR, Bieniek KF, Richardson TE. COVID-19 patients with CNS complications and neuropathologic features of acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalopathy. J Neuropathol Exp Neurol 2021; 80 (06) 628-631
• 42 Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: systematic review and meta-synthesis. Neurol Neuroimmunol Neuroinflamm 2021; 8 (06) 8
• 43 Sriwastava S, Sharma K, Khalid SH. et al. COVID-19 vaccination and neurological manifestations: a review of case reports and case series. Brain Sci 2022; 12 (03) 12
• 44 Maccio U, Zinkernagel AS, Schuepbach R. et al. Long-term persisting SARS-CoV-2 RNA and pathological findings: lessons learnt from a series of 35 COVID-19 autopsies. Front Med (Lausanne) 2022; 9: 778489
• 45 Ondruschka B, Heinrich F, Lindenmeyer M. et al. Multiorgan tropism of SARS-CoV-2 lineage B.1.1.7. Int J Legal Med 2021; 135 (06) 2347-2349
• 46 Seyedjavadi SS, Bagheri P, Nasiri MJ, Razzaghi-Abyaneh M, Goudarzi M. Fungal infection in co-infected patients with COVID-19: an overview of case reports/case series and systematic review. Front Microbiol 2022; 13: 888452
• 47 Horby P, Lim WS, Emberson JR. et al; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021; 384 (08) 693-704
• 48 Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world. Mycopathologia 2021; 186 (06) 739-754
• 49 Hanley B, Naresh KN, Roufosse C. et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe 2020; 1 (06) e245-e253
• 50 Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021; 15 (04) 102146
• 51 Krishna V, Morjaria J, Jalandari R, Omar F, Kaul S. Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection. IDCases 2021; 25: e01172
• 52 Sekaran A, Patil N, Sabhapandit S, Sistla SK, Reddy DN. Rhino-orbito-cerebral mucormycosis: an epidemic in a pandemic. IJID Reg 2022; 2: 99-106
• 53 American Association of Neuropathologists, Inc. Abstracts of the 98th Annual Meeting June 9-12, 2022 Bonita Springs, Florida. J Neuropathol Exp Neurol 2022; 81 (06) 437-499
• 54 Rajan S, Khunti K, Alwan N. et al. In the Wake of the Pandemic. Preparing for Long COVID. Policy Brief, No. 39. Copenhagen: European Observatory on Health Systems and Policies; 2021
• 55 Chertow D, Stein S, Ramelli S. et al. SARS-CoV-2 infection and persistence throughout the human body and brain. 2021 Available at: https://doi.org/10.21203/rs.3.rs-1139035/v1
• 56 Swank Z, Senussi Y, Manickas-Hill Z. et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis 2023; 76 (03) e487-e490
• 57 Zollner A, Koch R, Jukic A. et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology 2022; 163 (02) 495-506 .e8
• 58 Martin MDGM, Paes VR, Cardoso EF. et al. Postmortem brain 7T MRI with minimally invasive pathological correlation in deceased COVID-19 subjects. Insights Imaging 2022; 13 (01) 7
• 59 Muñoz-Fontela C, Dowling WE, Funnell SGP. et al. Animal models for COVID-19. Nature 2020; 586 (7830): 509-515
• 60 Pandamooz S, Jurek B, Meinung CP. et al. Experimental models of SARS-CoV-2 infection: possible platforms to study COVID-19 pathogenesis and potential treatments. Annu Rev Pharmacol Toxicol 2022; 62: 25-53
• 61 Khoury DS, Wheatley AK, Ramuta MD. et al. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol 2020; 20 (12) 727-738
• 62 Ramani A, Müller L, Ostermann PN. et al. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J 2020; 39 (20) e106230
• 63 McMahon CL, Staples H, Gazi M, Carrion R, Hsieh J. SARS-CoV-2 targets glial cells in human cortical organoids. Stem Cell Reports 2021; 16 (05) 1156-1164
• 64 Song E, Zhang C, Israelow B. et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 2021; 218 (03) 218
• 65 Pellegrini L, Albecka A, Mallery DL. et al. SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell 2020; 27 (06) 951-961 .e5
• 66 Crunfli F, Carregari VC, Veras FP. et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci U S A 2022; 119 (35) e2200960119
• 67 Andrews MG, Mukhtar T, Eze UC. et al. Tropism of SARS-CoV-2 for human cortical astrocytes. Proc Natl Acad Sci U S A 2022; 119 (30) e2122236119
• 68 Philippens IHCHM, Böszörményi KP, Wubben JAM. et al. Brain inflammation and intracellular α-synuclein aggregates in macaques after SARS-CoV-2 infection. Viruses 2022; 14 (04) 14
• 69 Rutkai I, Mayer MG, Hellmers LM. et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun 2022; 13 (01) 1745
• 70 Vanderheiden A, Klein RS. Neuroinflammation and COVID-19. Curr Opin Neurobiol 2022; 76: 102608
• 71 Normandin E, Holroyd KB, Collens SI. et al. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients. J Neurol Sci 2021; 430: 120023
• 72 Lersy F, Benotmane I, Helms J. et al. Cerebrospinal fluid features in patients with coronavirus disease 2019 and neurological manifestations: correlation with brain magnetic resonance imaging findings in 58 patients. J Infect Dis 2021; 223 (04) 600-609
• 73 Edén A, Kanberg N, Gostner J. et al. CSF biomarkers in patients with COVID-19 and neurologic symptoms: a case series. Neurology 2021; 96 (02) e294-e300
• 74 Remsik J, Wilcox JA, Babady NE. et al. Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients. Cancer Cell 2021; 39 (02) 276-283 .e3
• 75 Schwabenland M, Salié H, Tanevski J. et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity 2021; 54 (07) 1594-1610 .e11
• 76 Fernández-Castañeda A, Lu P, Geraghty AC. et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 2022; 185 (14) 2452-2468 .e16
• 77 Peluso MJ, Sans HM, Forman CA. et al. Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 2022; 9 (05) 9
• 78 Zhang L, Zhou L, Bao L. et al. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther 2021; 6 (01) 337
• 79 Villeda SA, Luo J, Mosher KI. et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011; 477 (7362): 90-94
• 80 Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer's-like signaling in brains of COVID-19 patients. Alzheimers Dement 2022; 18 (05) 955-965
• 81 Cai Y, Kim DJ, Takahashi T. et al; Yale IMPACT Research team. Kynurenic acid may underlie sex-specific immune responses to COVID-19. Sci Signal 2021; 14 (690) 14
• 82 Thomas T, Stefanoni D, Reisz JA. et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 2020; 5 (14) 5
• 83 Edler C, Schröder AS, Aepfelbacher M. et al. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med 2020; 134 (04) 1275-1284
• 84 Rhea EM, Logsdon AF, Hansen KM. et al. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat Neurosci 2021; 24 (03) 368-378
• 85 Cain MD, Salimi H, Diamond MS, Klein RS. Mechanisms of pathogen invasion into the central nervous system. Neuron 2019; 103 (05) 771-783
• 86 WHO. coronavirus (COVID-19) dashboard. Available at: https://covid19.who.int/ . Accessed September 10, 2022
• 87 Yoo KJ, Mehta A, Mak J, Bishai D, Chansa C, Patenaude B. COVAX and equitable access to COVID-19 vaccines. Bull World Health Organ 2022; 100 (05) 315-328
• 88 Singh A, Arulogun O, Akinyemi J. et al. Biological sample donation and informed consent for neurobiobanking: evidence from a community survey in Ghana and Nigeria. PLoS One 2022; 17 (08) e0267705
• 89 Akinyemi RO, Salami A, Akinyemi J. et al. Brain banking in low and middle-income countries: raison d'être for the Ibadan Brain Ageing, Dementia And Neurodegeneration (IBADAN) Brain Bank Project. Brain Res Bull 2019; 145: 136-141